{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:23:54Z","timestamp":1793071434348,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17K15531"],"award-info":[{"award-number":["JP17K15531"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bbrc.2021.09.041","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T02:01:22Z","timestamp":1632276082000},"page":"157-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Combination of azacytidine and curcumin is a potential alternative in decitabine-resistant colorectal cancer cells with attenuated deoxycytidine kinase"],"prefix":"10.1016","volume":"578","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8000-4471","authenticated-orcid":false,"given":"Mika","family":"Hosokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risako","family":"Seiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Iwakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Ogawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.09.041_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2014.08.010","article-title":"Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors","volume":"354","author":"Nie","year":"2014","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2021.09.041_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","article-title":"Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine","volume":"123","author":"Stresemann","year":"2008","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.bbrc.2021.09.041_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.leukres.2014.08.016","article-title":"The hENT1 and DCK genes underlie the decitabine response in patients with myelodysplastic syndrome","volume":"39","author":"Wu","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2021.09.041_bib4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3892\/ol.2015.3253","article-title":"Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabine","volume":"10","author":"Hosokawa","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2021.09.041_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbrc.2018.12.115","article-title":"Decitabine exerted synergistic effects with oxaliplatin in colorectal cancer cells with intrinsic resistance to decitabine","volume":"509","author":"Hosokawa","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.09.041_bib6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.fct.2018.10.052","article-title":"An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs","volume":"123","author":"Huang","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbrc.2021.09.041_bib7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/1568026615666150825141505","article-title":"DNA methyltransferases inhibitors from natural sources","volume":"16","author":"Zwergel","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbrc.2021.09.041_bib8","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1093\/nar\/gkp383","article-title":"Quantitative evaluation of DNA methylation by optimization of a differential-high resolution melt analysis protocol","volume":"37","author":"Malentacchi","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2021.09.041_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4161\/epi.9020","article-title":"Primer design versus PCR bias in methylation independent PCR amplifications","volume":"4","author":"Wojdacz","year":"2009","journal-title":"Epigenetics"},{"key":"10.1016\/j.bbrc.2021.09.041_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbrc.2021.09.041_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng892","article-title":"A\u00a0genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer","volume":"31","author":"Suzuki","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2021.09.041_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood-2008-02-140038","article-title":"Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines","volume":"113","author":"Qin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2021.09.041_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2012.03.122","article-title":"DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells","volume":"421","author":"Saiki","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.09.041_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s002800050832","article-title":"Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells","volume":"42","author":"Eliopoulos","year":"1998","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2021.09.041_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/sj.cgt.7700358","article-title":"Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene","volume":"8","author":"Beaus\u00e9jour","year":"2001","journal-title":"Canc. Gene Ther."},{"key":"10.1016\/j.bbrc.2021.09.041_bib16","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1007\/s11095-012-0728-2","article-title":"Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cells","volume":"29","author":"Ohmine","year":"2012","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.bbrc.2021.09.041_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.leukres.2010.04.014","article-title":"3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase","volume":"35","author":"Raynal","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2021.09.041_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bcp.2014.03.008","article-title":"Constitutive activation of the ATM\/BRCA1 pathway prevents DNA damage-induced apoptosis in 5-azacytidine-resistant cell lines","volume":"89","author":"Imanishi","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2021.09.041_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts cell","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2021.09.041_bib20","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1158\/1535-7163.MCT-19-0745","article-title":"Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance","volume":"19","author":"Dahn","year":"2020","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2021.09.041_bib21","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1586\/era.09.119","article-title":"HuR modulates gemcitabine efficacy: new perspectives in pancreatic cancer treatment","volume":"9","author":"Mar\u00e9chal","year":"2009","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.bbrc.2021.09.041_bib22","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1158\/0008-5472.CAN-09-0371","article-title":"The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase","volume":"69","author":"Costantino","year":"2009","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2021.09.041_bib23","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1080\/15257770.2011.629271","article-title":"Regulation of deoxycytidine kinase expression and sensitivity to gemcitabine by micro-RNA 330 and promoter methylation in cancer cells","volume":"30","author":"Hodzic","year":"2011","journal-title":"Nucleos Nucleot. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2021.09.041_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057709","article-title":"Curcumin modulates DNA methylation in colorectal cancer cells","volume":"8","author":"Link","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2021.09.041_bib25","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jnutbio.2014.11.017","article-title":"Sensitization to docetaxel in prostate cancer cells by green tea and quercetin","volume":"26","author":"Wang","year":"2015","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.bbrc.2021.09.041_bib26","first-page":"6869","article-title":"The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol","volume":"18","author":"Cho","year":"2019","journal-title":"Oncol. Lett."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21013358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21013358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:11:44Z","timestamp":1757765504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21013358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":26,"alternative-id":["S0006291X21013358"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.09.041","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of azacytidine and curcumin is a potential alternative in decitabine-resistant colorectal cancer cells with attenuated deoxycytidine kinase","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}